Biotechnology The Most Important Catalyst For Merck’s Stock In 2024 Could Be Sotatercept Launch, Analyst Says – Merck & Co (NYSE:MRK) Read more
Stockpicks Nio’s Perfect Storm: Weak Deliveries, Price Wars, and Analyst Downgrades Spell Disaster Read more
Biotechnology Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform – Voyager Therapeutics (NASDAQ:VYGR) Read more
Biotechnology Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Trial Data – Immuneering (NASDAQ:IMRX) Read more
Biotechnology FDA Approves Mirum’s Livmarli For Liver Disease In Kids As Young As 5 Years: Analyst Bullish On Label Expansion Strategy – Mirum Pharmaceuticals (NASDAQ:MIRM) Read more
Biotechnology Neuromuscular Focused-Avidity Biosciences Has ‘Complete Package’ – Analyst Predicts Stellar 142% Stock Surge – Avidity Biosciences (NASDAQ:RNA) Read more
Biotechnology Skin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggers – AnaptysBio (NASDAQ:ANAB) Read more
Biotechnology This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO – Regenxbio (NASDAQ:RGNX) Read more
Biotechnology ALX Oncology Has ‘Elevated Valuation’ – Analyst Downgrades Stock, Highlights Need For Development De-Risking Beyond Gastric Cancer – ALX Oncology Holdings (NASDAQ:ALXO) Read more